Inactive Instrument
Bellicum Pharmaceuticals, Inc. Stock OTC Markets
Stocks
BLCM
US0794814048
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -6.68% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dave Maggio
CEO | Chief Executive Officer | 66 | 2024-02-22 |
Richard Fair
CEO | Chief Executive Officer | 57 | 2017-01-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Richard Fair
BRD | Director/Board Member | 57 | - |
Judith Kilmovsky
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.68% | -18.17% | - | - | 822K | |
| +0.68% | +5.92% | +77.86% | +136.97% | 59.1B | |
| +2.32% | +5.03% | +75.26% | +92.31% | 55.19B | |
| +3.86% | +6.93% | -11.32% | -10.57% | 24.67B | |
| +4.30% | +7.95% | +14.11% | +440.44% | 24.19B | |
| +1.92% | +8.96% | +53.45% | +0.63% | 19.69B | |
| -0.29% | +9.78% | +43.90% | -29.12% | 17.56B | |
| 0.00% | +20.78% | +186.15% | +347.42% | 16.22B | |
| +6.61% | +22.25% | +51.11% | - | 14.84B | |
| +3.50% | +1.97% | +21.02% | +193.33% | 14.04B | |
| Average | +1.67% | +8.57% | +56.84% | +146.43% | 27.28B | |
| Weighted average by Cap. | +2.27% | +6.47% | +59.94% | +136.28% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 6.2M 5.42M 4.98M 4.64M 8.81M 590M 8.94M 59.8M 23.25M 290M 23.27M 22.77M 1B | 1.5M 1.31M 1.21M 1.12M 2.13M 143M 2.16M 14.47M 5.62M 70.2M 5.63M 5.51M 242M |
| Net income | -9.7M -8.48M -7.8M -7.27M -13.78M -924M -13.99M -93.6M -36.39M -454M -36.43M -35.65M -1.57B | -24.97M -21.83M -20.06M -18.7M -35.47M -2.38B -36.01M -241M -93.63M -1.17B -93.74M -91.73M -4.03B |
| Net Debt | - | - |
Employees
13
